End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28,100 KRW | -0.18% | +0.72% | +4.07% |
2023 | Vieworks Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2023 | Vieworks' Vivix X-Ray Flat Panel Detector Full Line-Up to Be Showcased At Ecr 2023 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 10.78 for the current year.
- The company appears to be poorly valued given its net asset value.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The opinion of analysts covering the stock has improved over the past four months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.07% | 188M | - | ||
-4.01% | 14.91B | - | ||
-14.59% | 2.41B | - | ||
-11.01% | 1.48B | - | - | |
-.--% | 1.12B | - | - | |
+58.24% | 583M | - | ||
+94.87% | 515M | B+ | ||
+12.77% | 244M | C | ||
+0.12% | 230M | - | - | |
-.--% | 179M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- A100120 Stock
- Ratings Vieworks Co., Ltd.